| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT02955290 CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced… |
date change Primary completion pushed: 2025-05-23 -> 2026-11-25 |
| 2026-08-08 | NCT02455557 SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed… |
date change Completion pushed: 2026-06-02 -> 2026-09-02 |
| 2026-08-08 | NCT06305598 Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for… |
Enrollment closed, study ongoing |
| 2026-08-08 | NCT06305598 Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for… |
Enrollment reduced: 14 -> 3 participants |
| 2026-08-08 | NCT06305598 Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for… |
date change Primary completion moved earlier: 2029-12-15 -> 2026-03-09 |
| 2026-08-08 | NCT06305598 Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for… |
date change Completion moved earlier: 2029-12-15 -> 2028-03-09 |
| 2026-08-07 | NCT04876248 Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients… |
date change Primary completion pushed: 2026-09-01 -> 2026-12-01 |
| 2026-08-04 | NCT04646434 Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing… |
critical Recruitment suspended |
| 2026-08-04 | NCT04646434 Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing… |
critical Recruitment suspended: Protocol being updates and staff trained |
| 2026-08-01 | NCT07679334 Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the… |
date change Primary completion pushed: 2028-08-01 -> 2028-09-01 |
| 2026-08-01 | NCT07679334 Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the… |
date change Completion pushed: 2029-08-01 -> 2029-09-01 |
| 2026-07-30 | NCT06681077 A Community Health Education Intervention for Increasing Community-driven Actions to… |
Primary endpoint(s) modified |
| 2026-07-30 | NCT06681077 A Community Health Education Intervention for Increasing Community-driven Actions to… |
Trial arms changed: 1 -> 2 |
| 2026-07-29 | NCT06029517 A Sugar-Sweetened Beverage Reduction Intervention for Native American Men |
Trial completed |
| 2026-07-29 | NCT06029517 A Sugar-Sweetened Beverage Reduction Intervention for Native American Men |
date change Completion moved earlier: 2026-09-15 -> 2025-09-15 |
| 2026-07-24 | NCT06320717 AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic… |
date change Primary completion pushed: 2026-07-02 -> 2026-12-02 |
| 2026-07-24 | NCT06320717 AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic… |
date change Completion pushed: 2026-07-02 -> 2026-12-02 |
| 2026-07-22 | NCT04348747 Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain… |
date change Primary completion pushed: 2027-06-15 -> 2028-05-15 |
| 2026-07-22 | NCT04348747 Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain… |
date change Completion pushed: 2027-12-15 -> 2028-05-15 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-04 | NCT07745023 Mind-Body Interventions for the Improvement of Quality of Life, Stress, and Sleep Quality… | Not Yet Recruiting | |
| 2026-07-22 | NCT07718672 Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative… | Phase 2 | Not Yet Recruiting |
| 2026-07-20 | NCT07714018 Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06733350 | Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men… | Localized Prostate Carcinoma | Recruiting |
| Phase 3 | |||
| NCT06563388 | Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic… | Oligometastasis | Recruiting |
| Phase 2 | |||
| NCT04696575 | Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage… | Extensive Stage Lung Small Cell Carcinoma | Recruiting |
| NCT05651594 | Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment… | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Recruiting |
| NCT04682158 | Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma | Esophageal Adenocarcinoma | Recruiting |
| NCT06627751 | Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory… | Extramedullary Disease in Multiple Myeloma | Recruiting |
| NCT06995508 | Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing… | Cancer-Associated Anorexia | Recruiting |
| NCT04919629 | APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab… | Fallopian Tube Carcinosarcoma | Recruiting |
| NCT06821997 | NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal… | Borderline Resectable Pancreatic Ductal Adenocarcinoma | Recruiting |
| NCT06434064 | Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With… | Anatomic Stage III Breast Cancer AJCC v8 | Recruiting |
| NCT04068649 | Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients… | Metastatic Malignant Neoplasm | Recruiting |
| NCT06733363 | A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and… | Non-Muscle Invasive Bladder Carcinoma | Recruiting |
| NCT04067830 | Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients… | Stage I Lung Cancer AJCC v8 | Recruiting |
| NCT06202066 | Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients… | Digestive System Neuroendocrine Neoplasm | Recruiting |
| NCT06863402 | Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse… | Richter Syndrome | Recruiting |
| NCT04348747 | Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT07017829 | GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11… | Advanced Lung Non-Small Cell Carcinoma | Recruiting |
| NCT05231122 | Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for… | Ovarian Clear Cell Adenocarcinoma | Recruiting |
| NCT04269213 | CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60… | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Active, Not Recruiting |
| NCT04032418 | Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small… | Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| NCT03899987 | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT06943664 | Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory… | Lung Non-Small Cell Carcinoma | Not Yet Recruiting |
| NCT07543172 | CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non… | Advanced Lung Non-Small Cell Carcinoma | Not Yet Recruiting |
| NCT07718672 | Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative… | Early Stage Lung Non-Small Cell Carcinoma | Not Yet Recruiting |
| NCT04876248 | Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients… | Plasma Cell Myeloma | Active, Not Recruiting |